Schwarzenbach, C.; Tatsch, L.; Brandstetter Vilar, J.; Rasenberger, B.; Beltzig, L.; Kaina, B.; Tomicic, M.T.; Christmann, M.
Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment. Cancers 2021, 13, 3585.
https://doi.org/10.3390/cancers13143585
AMA Style
Schwarzenbach C, Tatsch L, Brandstetter Vilar J, Rasenberger B, Beltzig L, Kaina B, Tomicic MT, Christmann M.
Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment. Cancers. 2021; 13(14):3585.
https://doi.org/10.3390/cancers13143585
Chicago/Turabian Style
Schwarzenbach, Christian, Larissa Tatsch, Juliana Brandstetter Vilar, Birgit Rasenberger, Lea Beltzig, Bernd Kaina, Maja T. Tomicic, and Markus Christmann.
2021. "Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment" Cancers 13, no. 14: 3585.
https://doi.org/10.3390/cancers13143585
APA Style
Schwarzenbach, C., Tatsch, L., Brandstetter Vilar, J., Rasenberger, B., Beltzig, L., Kaina, B., Tomicic, M. T., & Christmann, M.
(2021). Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment. Cancers, 13(14), 3585.
https://doi.org/10.3390/cancers13143585